NEW YORK (GenomeWeb News) – French life science firm Cytoo announced today that it, Cellectis Bioresearch, and the French Alternative Energies and Atomic Energy Commission (CEA) are partnering to develop cell-based assays for drug development and toxicology.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have an account?
Login Now.